Histogen Ownership 2024 | Who Owns Histogen Now?


OverviewRevenueFinancialsChart

Institutional Ownership

8.02%

Insider Ownership

2.85%

Retail Ownership

89.13%

Institutional Holders

17.00

Histogen Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC1.87%-60,16646,528341.16%72,801,000Mar 31, 2023
BLACKROCK INC.1.09%-34,910--42,241,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.83%-26,53626,536100.00%32,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.48%-15,48715,487100.00%18,739,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.40%0.00%12,8232,72026.92%15,516,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.32%-10,387--12,568,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.24%0.00%7,716-3,013-28.08%9,000Mar 31, 2023
UBS GROUP AG0.20%-6,3411,81440.07%7,673,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.0.01%-375375100.00%454,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-30-32-51.61%36,000Mar 31, 2023
COMPAGNIE LOMBARD ODIER SCMA0.00%-1515100.00%18,000Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC0.00%-1515100.00%12,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO--11100.00%1,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----10,600-100.00%-Mar 31, 2023
JANE STREET GROUP, LLC----13,182-100.00%-Mar 31, 2023

Histogen's largest institutional shareholder is VANGUARD GROUP INC, holding 1.87% of the company's total share outstanding, currently valued at $72.80M. The top 10 institutional shareholders own together 5.44% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TWO SIGMA SECURITIES, LLC0.40%0.00%12,8232,72026.92%15,516,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.24%0.00%7,716-3,013-28.08%9,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.83%-26,53626,536100.00%32,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.48%-15,48715,487100.00%18,739,000Mar 31, 2023
UBS GROUP AG0.20%-6,3411,81440.07%7,673,000Mar 31, 2023
VANGUARD GROUP INC1.87%-60,16646,528341.16%72,801,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.32%-10,387--12,568,000Mar 31, 2023
BLACKROCK INC.1.09%-34,910--42,241,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.0.01%-375375100.00%454,000Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC0.00%-1515100.00%12,000Mar 31, 2023
COMPAGNIE LOMBARD ODIER SCMA0.00%-1515100.00%18,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-30-32-51.61%36,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO--11100.00%1,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----10,600-100.00%-Mar 31, 2023
JANE STREET GROUP, LLC----13,182-100.00%-Mar 31, 2023

The largest Histogen shareholder by % of total assets is TWO SIGMA SECURITIES, LLC. The company owns 12.82K shares of Histogen (HSTO), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC1.87%-60,16646,528341.16%72,801,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.83%-26,53626,536100.00%32,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.48%-15,48715,487100.00%18,739,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.40%0.00%12,8232,72026.92%15,516,000Mar 31, 2023
UBS GROUP AG0.20%-6,3411,81440.07%7,673,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.0.01%-375375100.00%454,000Mar 31, 2023
COMPAGNIE LOMBARD ODIER SCMA0.00%-1515100.00%18,000Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC0.00%-1515100.00%12,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO--11100.00%1,000Mar 31, 2023
BLACKROCK INC.1.09%-34,910--42,241,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.32%-10,387--12,568,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-30-32-51.61%36,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.24%0.00%7,716-3,013-28.08%9,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----10,600-100.00%-Mar 31, 2023
JANE STREET GROUP, LLC----13,182-100.00%-Mar 31, 2023

As of Mar 31 2023, Histogen's largest institutional buyer is VANGUARD GROUP INC. The company purchased 46.53K stocks of HSTO, valued at $72.80M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANE STREET GROUP, LLC----13,182-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----10,600-100.00%-Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)0.24%0.00%7,716-3,013-28.08%9,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-30-32-51.61%36,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.32%-10,387--12,568,000Mar 31, 2023
BLACKROCK INC.1.09%-34,910--42,241,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO--11100.00%1,000Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC0.00%-1515100.00%12,000Mar 31, 2023
COMPAGNIE LOMBARD ODIER SCMA0.00%-1515100.00%18,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.0.01%-375375100.00%454,000Mar 31, 2023
UBS GROUP AG0.20%-6,3411,81440.07%7,673,000Mar 31, 2023
TWO SIGMA SECURITIES, LLC0.40%0.00%12,8232,72026.92%15,516,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.48%-15,48715,487100.00%18,739,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.83%-26,53626,536100.00%32,000Mar 31, 2023
VANGUARD GROUP INC1.87%-60,16646,528341.16%72,801,000Mar 31, 2023

As of Mar 31 2023, Histogen's biggest institutional seller is JANE STREET GROUP, LLC. The company sold -13.18K shares of HSTO, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC0.83%-26,53626,536100.00%32,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.48%-15,48715,487100.00%18,739,000Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.0.01%-375375100.00%454,000Mar 31, 2023
COMPAGNIE LOMBARD ODIER SCMA0.00%-1515100.00%18,000Mar 31, 2023
GLOBAL RETIREMENT PARTNERS, LLC0.00%-1515100.00%12,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO--11100.00%1,000Mar 31, 2023

Histogen's largest new institutional shareholder by number of shares is MILLENNIUM MANAGEMENT LLC, purchased 26.54K shares, valued at $32.00K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANE STREET GROUP, LLC----13,182-100.00%-Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC----10,600-100.00%-Mar 31, 2023

Histogen's largest sold out institutional shareholder by shares sold is JANE STREET GROUP, LLC, sold -13.18K shares, valued at -, as of undefined.

Histogen Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD INDEX FUNDS0.00%972,297--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%207,567--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%60,166--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%10,249--Feb 29, 2024
USAA MUTUAL FUNDS TRUST0.00%6,952--Jan 31, 2024

Histogen's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 972.30K shares, compromising 0.00% of its total assets.

Histogen Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2217-10.53%
31 Dec, 2119-5.00%
30 Sep, 212011.11%
30 Jun, 2118-14.29%
31 Mar, 212140.00%
31 Dec, 20157.14%
30 Sep, 2014-
30 Jun, 2014-

As of 31 Mar 22, 17 institutions are holding Histogen's shares, representing a decrease of -10.53% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 224,005,332-51.82%
31 Dec, 218,313,939192.57%
30 Sep, 212,841,7113.62%
30 Jun, 212,742,51763.62%
31 Mar, 211,676,104218.51%
31 Dec, 20526,225-10.11%
30 Sep, 20585,4230.94%
30 Jun, 20579,982-

Histogen (HSTO) has 4.01M shares outstanding as of 31 Mar 22, down -51.82% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 228.02%1.71%
31 Dec, 2121.67%46.73%
30 Sep, 216.81%12.53%
30 Jun, 217.37%26.16%
31 Mar, 215.31%191.09%
31 Dec, 201.67%48.48%
30 Sep, 201.85%54.95%
30 Jun, 201.84%-

As of 31 Mar 22, Histogen is held by 8.02% institutional shareholders, representing a 1.71% growth compared to 31 Dec 21.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 227-36.36%
31 Dec, 2111-8.33%
30 Sep, 21129.09%
30 Jun, 2111-31.25%
31 Mar, 2116166.67%
31 Dec, 20620.00%
30 Sep, 205-64.29%
30 Jun, 2014-

7 institutional shareholders have increased their position in HSTO stock as of 31 Mar 22 compared to 11 in the previous quarter (a -36.36% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 22350.00%
31 Dec, 212-50.00%
30 Sep, 21433.33%
30 Jun, 213-
31 Mar, 21--100.00%
31 Dec, 203-
30 Sep, 203-
30 Jun, 20--

3 institutional shareholders have reduced their position in HSTO stock as of 31 Mar 22 compared to 2 in the previous quarter (a 50.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2217-10.53%4,005,332-51.82%8.02%1.71%7-36.36%350.00%
31 Dec, 2119-5.00%8,313,939192.57%21.67%46.73%11-8.33%2-50.00%
30 Sep, 212011.11%2,841,7113.62%6.81%12.53%129.09%433.33%
30 Jun, 2118-14.29%2,742,51763.62%7.37%26.16%11-31.25%3-
31 Mar, 212140.00%1,676,104218.51%5.31%191.09%16166.67%--100.00%
31 Dec, 20157.14%526,225-10.11%1.67%48.48%620.00%3-
30 Sep, 2014-585,4230.94%1.85%54.95%5-64.29%3-
30 Jun, 2014-579,982-1.84%-14---

Histogen Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 28, 2023Reyes Joyceofficer See RemarksD-ReturnSell4,452$4.80$21.37K-
Apr 28, 2023Reyes Joyceofficer See RemarksD-ReturnSell7,833$3.20$25.07K-
Mar 14, 2023Reyes Joyceofficer See RemarksD-ReturnSell1,200$4.80$5.76K-
Mar 14, 2023Reyes Joyceofficer See RemarksD-ReturnSell7,833$3.20$25.07K-
Mar 14, 2023Knudson Susan A.officer COO and CFOD-ReturnSell6,206$92.20$572.19K-
Mar 14, 2023Knudson Susan A.officer COO and CFOD-ReturnSell5,600$19.40$108.64K-
Mar 14, 2023Knudson Susan A.officer COO and CFOD-ReturnSell8,490$4.80$40.75K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 21, 2023Windham-Bannister Susan Richardsdirector-A-AwardBuy6,835$0.83$5.66K6,835
Jun 21, 2023Satz Briandirector-A-AwardBuy6,835$0.83$5.66K6,835
Jun 21, 2023KISNER DANIEL Ldirector-A-AwardBuy6,835$0.83$5.66K6,835
Jun 21, 2023Jackson Jonathandirector-A-AwardBuy6,835$0.83$5.66K6,835
Jun 21, 2023Fuhrmann Rochelledirector-A-AwardBuy6,835$0.83$5.66K6,835
Jun 21, 2023Crean David Hughdirector-A-AwardBuy6,835$0.83$5.66K6,835
Apr 28, 2023Reyes Joyceofficer See RemarksA-AwardBuy47,417$0.95$45.05K47,417
Apr 28, 2023Reyes Joyceofficer See RemarksA-AwardBuy16,659$0.95$15.83K16,659
Apr 28, 2023Reyes Joyceofficer See RemarksD-ReturnSell4,452$4.80$21.37K-
Apr 28, 2023Reyes Joyceofficer See RemarksD-ReturnSell7,833$3.20$25.07K-
Mar 14, 2023Reyes Joyceofficer See RemarksA-AwardBuy47,417$0.95$45.05K47,417
Mar 14, 2023Reyes Joyceofficer See RemarksA-AwardBuy16,659$0.95$15.83K16,659
Mar 14, 2023Reyes Joyceofficer See RemarksD-ReturnSell1,200$4.80$5.76K-
Mar 14, 2023Reyes Joyceofficer See RemarksD-ReturnSell7,833$3.20$25.07K-
Mar 14, 2023Knudson Susan A.officer COO and CFOA-AwardBuy79,027$0.95$75.08K79,027
Mar 14, 2023Knudson Susan A.officer COO and CFOA-AwardBuy27,766$0.95$26.38K27,766
Mar 14, 2023Knudson Susan A.officer COO and CFOD-ReturnSell6,206$92.20$572.19K-
Mar 14, 2023Knudson Susan A.officer COO and CFOD-ReturnSell5,600$19.40$108.64K-
Mar 14, 2023Knudson Susan A.officer COO and CFOD-ReturnSell8,490$4.80$40.75K-
Mar 14, 2023Mento Steven Jdirector, officer President and CEOA-AwardBuy158,055$0.95$150.15K158,055

The last insider sell of Histogen's stock was made by Reyes Joyce on Apr 28 2023, selling 4,452 shares at $4.80 per share (valued at $21.37K).

Histogen Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20236--
Q1 202391090.00%
Q4 2022-2-
Q2 202271700.00%
Q1 20223--
Q4 20214--
Q3 20215--
Q1 20218--
Q4 20209--
Q2 2020106166.67%
Q4 20191--
Q3 201942317.39%
Q2 20195--
Q1 20199--
Q4 20182--
Q2 20181211200.00%
Q1 201891900.00%
Q4 20173--
Q3 20171--
Q2 20177--

6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Histogen's insiders, as of Q2 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2023---
Q1 2023---
Q4 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q1 20211--
Q4 20201--
Q2 2020---
Q4 2019---
Q3 2019---
Q2 2019---
Q1 2019---
Q4 2018---
Q2 2018---
Q1 2018---
Q4 2017---
Q3 2017---
Q2 2017---

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Histogen's stocks.

Histogen Peer Ownership


TickerCompany
SNTISenti Biosciences, Inc.
BLCMBellicum Pharmaceuticals, Inc.
NEXINexImmune, Inc.
TCONTRACON Pharmaceuticals, Inc.
ARTLArtelo Biosciences, Inc.
TNXPTonix Pharmaceuticals Holding Corp.
YSLakeShore Biopharma Co., Ltd
HILSTharimmune, Inc.
CINGCingulate Inc.
VRAXVirax Biolabs Group Limited
CYTOAltamira Therapeutics Ltd.
TPSTTempest Therapeutics, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
CRISCuris, Inc.
ENTXEntera Bio Ltd.
BXRXBaudax Bio, Inc.
DRUGBright Minds Biosciences Inc.
ALRNAileron Therapeutics, Inc.
PALIPalisade Bio, Inc.

HSTO Ownership FAQ


Histogen is owned by institutional shareholders (8.02%), insiders (2.85%), and public (89.13%). The largest institutional shareholder of Histogen is VANGUARD GROUP INC (1.87% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Histogen's major institutional shareholders are VANGUARD GROUP INC, BLACKROCK INC., MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 4.67% of the company's share outstanding.

As of Mar 2022, there are 17 institutional shareholders of Histogen.

VANGUARD GROUP INC owns 60.17K shares of Histogen, representing 1.87% of the company's total shares outstanding, valued at $72.8M (as of Mar 2023).

As of Mar 2023, BLACKROCK INC holds 34.91K shares of Histogen (HSTO), compromising 1.09% of the company, valued at $42.24M.

MILLENNIUM MANAGEMENT LLC is the third largest holder of Histogen. The company owns 26.54K of the company's shares outstanding (worth $32K).